Tang Capital
View Older Stories View More Recent Stories
-
Form SC 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Altimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A AVROBIO, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Genfit S.A. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tonix Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A BIONOMICS LIMITED/FI Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Bellerophon Therapeutics Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SC 13G/A Evolus, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Pyxis Oncology, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A bluebird bio, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Transcode Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A TCR2 THERAPEUTICS INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Quince Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A REVIVA PHARMACEUTICALS Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tharimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tarsus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A BioAtla, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A MEI Pharma, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Elevation Oncology, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Graphite Bio, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G PRECISION BIOSCIENCES Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Rain Oncology Inc. For: Jan 26 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Ventyx Biosciences, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Corbus Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A ASLAN Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D Reneo Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Theseus Pharmaceuticals (THRX) Acquired by Concentra Biosciences for $3.90-$4.05/sh Cash Plus CVR
-
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
-
Form 4 Rain Oncology Inc. For: Dec 14 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Tharimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
LianBio (LIAN) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
-
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
-
Form SC 13D LianBio Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Atea Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Kinnate Biopharma Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Theseus Pharmaceuticals (THRX) Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital and OrbiMed Advisors; Unsolicited Proposal from Concentra Biosciences
-
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
-
Form SC 13D Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Aclaris Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
-
Form SC 13G LianBio Filed by: TANG CAPITAL PARTNERS LP
-
Rain Oncology (RAIN) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences for $1.25 Plus CVR
-
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
-
Form 4 Rain Oncology Inc. For: Oct 11 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP

